Formosa Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Formosa Pharmaceuticals Inc. is a listed biotech company in Taiwan (6838.TW) promotes its proprietary APNT® nanoparticle formulation technology and lead assets in ophthalmology & oncology. The leading asset, APP13007, a treatment for inflammation and pain after ocular surgery, was derived from APNT® formulation technologyapproved by US FDA in 2024.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}